Switch to:
Synageva BioPharma Corp (NAS:GEVA)
EV/EBITDA
-35.04 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Synageva BioPharma Corp's enterprise value is $7,306.59 Mil. Synageva BioPharma Corp's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-208.53 Mil. Therefore, Synageva BioPharma Corp's EV/EBITDA ratio for today is -35.04.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Synageva BioPharma Corp's stock price is $215.79. Synageva BioPharma Corp's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-6.34. Therefore, Synageva BioPharma Corp's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Synageva BioPharma Corp's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=7306.585/-208.525
=-35.04

Synageva BioPharma Corp's current Enterprise Value is $7,306.59 Mil.
Synageva BioPharma Corp's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -48.57 (Jun. 2014 ) + -46.757 (Sep. 2014 ) + -55.666 (Dec. 2014 ) + -57.532 (Mar. 2015 ) = $-208.53 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Synageva BioPharma Corp's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=215.79/-6.343
=

Synageva BioPharma Corp's share price for today is $215.79.
Synageva BioPharma Corp's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -1.52 (Jun. 2014 ) + -1.46 (Sep. 2014 ) + -1.733 (Dec. 2014 ) + -1.63 (Mar. 2015 ) = $-6.34.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -31.8324.252.330.130.53-3.15-17.01-23.58-17.52-14.17

Synageva BioPharma Corp Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda -23.58-26.09-15.16-17.50-17.52-19.27-21.02-11.23-14.17-13.66
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK